title: Costing implications of recent treatment interruption studies.
authors.forename: M John
authors.initials: MJ
authors.lastname: Gill
authors.forename: Hartmut B
authors.initials: HB
authors.lastname: Krentz
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D018791:CD4 Lymphocyte Count; D003365:Costs and Cost Analysis; D018450:Disease Progression; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics*; D006801:Humans; D028761:Withholding Treatment / Q000191:economics